Investigating Hope and Expectations in Open-Label Placebos
NCT03517644 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2018-08-23
Summary
Research has shown that placebo effects contribute substantially to clinical outcomes. Recent evidence suggests that placebos remain effective even if they are openly described as placebos (so-called Open-Label Placebos). In this study, the investigators examine hope and expectations as components of open-label placebos in an experimental study investigating pain..
Conditions
Interventions
- OTHER
-
DP
Participants are informed that they are about to receive an effective analgesic cream. They are instructed to apply the cream using a cotton pad.
- OTHER
-
OLP Hope
Participants are informed that they are about to receive an placebo cream. They are told that the cream has no active pharmacological ingredient. Therefore, participants are supposed to evaluate the subjective probability for a positive effect of the cream as rather low. However, using verbal instructions, the investigator aims to induce hope among the participants that the cream could have a positive effect for them because this placebo cream did have a positive among some former participants who were similar to the current participant. The emphasis of this similarity (regarding age and sex) aims to induce a feeling of connectedness to previous participants who reported positive effects of the placebo cream.
- OTHER
-
OLP Expectation
Participants are informed that they are about to receive an placebo cream. They are told that the cream has no active pharmacological ingredient. However, participants are told that placebos have been shown to contribute substantially to clinical outcomes such as pain intensity/unpleasantness. This positive effect of placebos is reasoned by explaining learning mechanisms such as classical conditioning. We anticipated that after hearing this instruction, participants would consider it to be likely that the placebo has a positive effect for them.
- OTHER
-
Placebo cream
The participants receive an inert placebo cream (standard basic cream with oil of thyme produced by a local pharmacy).
- OTHER
-
Heat pain
Participant receive heat pain stimuli using the suprathreshold method of the Thermo Sensory Analyser (TSA-II), a commonly used device to study pain sensation and analgesic effects.
Sponsors & Collaborators
-
Philipps University Marburg
lead OTHER
Principal Investigators
-
Tobias Kube, M. Sc. · Philipps University Marburg
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- SINGLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 80 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-02-10
- Primary Completion
- 2018-06-30
- Completion
- 2018-08-21
Countries
- Germany
Study Locations
More Related Trials
-
Individualized Pharmaceutical-care in Outpatients With Cancer Pain
NCT03439904 ·Status: UNKNOWN ·Phase: NA
-
An Evaluation of the Effect of Community-based Pharmacist Intervention on Patients With Chronic Pain
NCT03087331 ·Status: COMPLETED ·Phase: NA
-
Paracetamol in Addition to WHO Step III Opioids in Chronic Cancer Pain Control
NCT05088876 ·Status: TERMINATED ·Phase: PHASE4
-
Prescription Medication Interactions
NCT04315181 ·Status: COMPLETED ·Phase: PHASE1
-
Individualized Pharmaceutical-care for Inpatients With Cancer Pain
NCT03455023 ·Status: UNKNOWN ·Phase: NA
-
Sensory Effects of Oral Opioid Treatment in Patients With Chronic Low Back Pain
NCT02824276 ·Status: COMPLETED ·Phase: PHASE1
-
Burn Healing and Analgesia With Propranolol
NCT00934947 ·Status: COMPLETED ·Phase: PHASE2
-
Patient Controlled Administration of Liquid Acetaminophen
NCT06498713 ·Status: RECRUITING ·Phase: PHASE1
-
Identification of Predictive Markers of the Effects of Opioid Therapy in Patients With Chronic Pain.
NCT03701672 ·Status: UNKNOWN
-
Effectiveness and Safety of Methadone Versus Placebo for the Control of Neuropathic Pain in Different Etiologies
NCT05235191 ·Status: COMPLETED ·Phase: PHASE3
-
Brain Effects of Opiate Agonist and Antagonist
NCT04342130 ·Status: COMPLETED ·Phase: PHASE4
-
Postoperative Pain Control in Septum and Sinus Surgery
NCT04149964 ·Status: COMPLETED ·Phase: PHASE4
-
Efficacy and Safety Study of NKTR-181 in Opioid-Naive Subjects With Low Back Pain
NCT02362672 ·Status: COMPLETED ·Phase: PHASE3
-
Prescribing Opioid Pain Relievers in the Emergency Department: Understanding and Optimizing the Encounter
NCT02299024 ·Status: COMPLETED ·Phase: NA
-
Open-Label Study to Evaluate the Effect of Treatment With Fentanyl Buccal Tablets on Pain Anxiety Symptoms When Used for the Management of Breakthrough Pain
NCT00387010 ·Status: TERMINATED ·Phase: PHASE3
-
Observational Study on the Patients With Pain Medications
NCT00771212 ·Status: COMPLETED
-
Chronic Pain Management During a Pandemic
NCT04370717 ·Status: COMPLETED
-
Study to Test the Effectiveness of Controlled-Release OROS® Hydromorphone HCl Compared to Placebo in Patients With Chronic Low Back Pain
NCT00549042 ·Status: COMPLETED ·Phase: PHASE3
-
Opiate-Induced Tolerance & Hyperalgesia in Pain Patients
NCT00246532 ·Status: COMPLETED ·Phase: PHASE4
-
Reduction in Pain Intensity Following IV or Oral Pain-relieving Products
NCT02678416 ·Status: COMPLETED ·Phase: PHASE4
-
Attenuation of Pain in Men and Women
NCT01220414 ·Status: COMPLETED ·Phase: NA
-
Improving Pain Disability With the Use of Oral Cannabinoids
NCT05351905 ·Status: COMPLETED ·Phase: NA
-
Study of Using Long Acting Antihistamine to Treat Opioid Induced Itching
NCT01825655 ·Status: TERMINATED ·Phase: PHASE4
-
Optimal Management of Pain in Hospitalized Patients - Opioid Tolerant Populations.
NCT02470728 ·Status: TERMINATED ·Phase: NA
-
Paracetamol for Cancer Pain
NCT01313247 ·Status: UNKNOWN ·Phase: PHASE4